3D SYSTEMS CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.505 USD | +3.39% |
|
-10.59% | -44.80% |
| Apr. 15 | 3D Systems Receives US FDA Clearance for 3D-Printed Cranial Implant | MT |
| Apr. 15 | 3D Systems Announces FDA Clearance for 3D-Printed Pek Cranial Implants | CI |
Financials (USD)
| Sales 2023 | 488M | Sales 2024 * | 482M | Capitalization | 453M |
|---|---|---|---|---|---|
| Net income 2023 | -370M | Net income 2024 * | -40M | EV / Sales 2023 | 1.74 x |
| Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.94 x |
| P/E ratio 2023 |
-2.23
x | P/E ratio 2024 * |
-10.8
x | Employees | 2,032 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 96.74% |
More Fundamentals
* Assessed data
More news
Latest transcript on 3D Systems Corporation
More recommendations
More press releases
| 1 day | -2.59% | ||
| 1 week | -16.09% | ||
| Current month | -23.65% | ||
| 1 month | -25.49% | ||
| 3 months | -27.87% | ||
| 6 months | -24.50% | ||
| Current year | -46.61% |
1 week
3.38
3.93
1 month
3.384.77
Current year
3.386.36
1 year
3.3811.09
3 years
3.3841.48
5 years
3.3856.50
10 years
3.3869.56
| Managers | Title | Age | Since |
|---|---|---|---|
Jeffrey Graves
CEO | Chief Executive Officer | 62 | 20-05-25 |
Charles Hull
FOU | Founder | 84 | 85-12-31 |
Jeffrey Creech
DFI | Director of Finance/CFO | 62 | Dec. 12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chip McClure
CHM | Chairman | 70 | 17-03-23 |
| Director/Board Member | 69 | 98-12-31 | |
Charles Hull
FOU | Founder | 84 | 85-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.97% | 152 M€ | -0.15% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 3.505 | +3.39% | 971 937 |
| 24-04-17 | 3.39 | -2.59% | 1,544,303 |
| 24-04-16 | 3.48 | -1.42% | 1,982,656 |
| 24-04-15 | 3.53 | -4.59% | 3,431,973 |
| 24-04-12 | 3.7 | -5.61% | 1,572,909 |
Delayed Quote Nyse, April 17, 2024 at 04:02 pm EDT
More quotes
3D Systems Corporation is an additive manufacturing solutions company. The Company is engaged in providing three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and digital design tools. The Companyâs segments include Healthcare Solutions and Industrial Solutions. Healthcare Solutions includes dental, medical devices, personalized health services and regenerative medicine. Industrial Solutions includes aerospace, defense, transportation and general manufacturing. The Company offers a range of 3D printing technologies, including Stereolithography (SLA), Selective Laser Sintering, Direct Metal Printing, MultiJet Printing, ColorJet Printing, polymer extrusion, and extrusion and SLA based bioprinting. The Company markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and the Asia Pacific and Oceania region.
Sector
Electronic Equipment & Parts
Calendar
2024-05-05
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
3.39
USD
Average target price
5.688
USD
Spread / Average Target
+67.77%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.61% | 453M | |
| +14.41% | 283M | |
| -34.15% | 108M | |
| -31.14% | 81.04M |
- Stock Market
- Equities
- DDD Stock
